3.12  0.02 (0.65%)		09-30 16:00
Open: 3.31 High: 3.31 Volume: 6,675		Pre. Close: 3.1 Low: 3.03 Market Cap: 5(M)

Short term
Mid term
Targets	6-month :	8	1-year :	10.76
Resists	First :	6.85	Second :	9.22
Pivot price	4.31
Supports	First :	3.02	Second :	2.52
MAs	MA(5) :	3.43	MA(20) :	4.43
	MA(100) :	6.08	MA(250) :	8.81
MACD	MACD :	-0.6	Signal :	-0.4
%K %D	K(14,3) :	0.9	D(3) :	0.7
RSI	RSI(14): 36
52-week	High :	21.71	Low :	3.02

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BMGL ] has closed above bottom band by 18.8%. Bollinger Bands are 66.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	3.32 - 3.34	3.34 - 3.36
Low:	2.98 - 3.01	3.01 - 3.03
Close:	3.08 - 3.12	3.12 - 3.16

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Wed, 23 Sep 2026
No minimum sale is required as Basel Medical Group (NASDAQ: BMGL) offers up to 6 million units at a set price. - Stock Titan

Mon, 13 Jul 2026
Basel Medical Group Ltd (BMGL) Declines as Stock Nears Key Support Level - Common Gap - careplusvn.com

Fri, 10 Jul 2026
Basel Medical Group Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement - Quiver Quantitative

Wed, 10 Jun 2026
Basel Medical to implement 1-for-12 reverse stock split By Investing.com - Investing.com UK

Tue, 06 May 2025
Basel Medical Group (BMGL) Stock Price, News & Analysis - Stock Titan

Mon, 03 Mar 2025
Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering - The Manila Times

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Care Facilities
Shares Out	2 (M)
Shares Float	1 (M)
Held by Insiders	54.3 (%)
Held by Institutions	0 (%)
Shares Short	11 (K)
Shares Short P.Month	33 (K)

EPS	-5.81
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.17
Profit Margin	-68.2 %
Operating Margin	-32.9 %
Return on Assets (ttm)	-15.5 %
Return on Equity (ttm)	-147.4 %
Qtrly Rev. Growth	67 %
Gross Profit (p.s.)	1.31
Sales Per Share	9.38
EBITDA (p.s.)	-2.59
Qtrly Earnings Growth	0 %
Operating Cash Flow	-2 (M)
Levered Free Cash Flow	-12 (M)

PE Ratio	-0.54
PEG Ratio	0
Price to Book value	0.98
Price to Sales	0.33
Price to Cash Flow	-2.6

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.